First drug to reverse Huntington’s disease begins human trials
A drug which appears to reverse Huntington’s disease is being trialled in humans after proving successful in monkeys and mice.
The new drug, called IONIS-HTTRx, silences the gene known to be responsible for the production of a protein which causes Huntington’s.
The disease is a hereditary condition which damages nerve cells in the brain and effects around 7,000 people in Britain. It causes uncontrolled movements, loss of intellectual abilities, emotional problems and eventually death.
More at Source: First drug to reverse Huntington’s disease begins human trials – Telegraph
Utah Standard News depends on the support of readers like you.
Good Journalism requires time, expertise, passion and money. We know you appreciate the coverage here. Please help us to continue as an alternative news website by becoming a subscriber or making a donation. To learn more about our subscription options or make a donation, click here.
To Advertise on UtahStandardNews.com, please contact us at: ed@utahstandardnews.com.
Comments - No Responses to “First drug to reverse Huntington’s disease begins human trials”
Sure is empty down here...